HARMONY BIOSCIENCES HOLDINGS, INC. financials

  1. Home
  2. Financials
  3. HRMY
HRMY CIK 0001802665

Source: EDGAR filings · Built 2026-06-02T03:14:23Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 347.89M 218.67M 219.07M 144.29M 98.26M -2.99M
EBITDA — 214.94M 216.39M 143.57M 106.37M 27.22M
Working Capital 654.88M 404.17M 287.29M 321.40M 230.66M 128.35M
Net Debt -583.25M -271.60M -115.58M -49.55M -38.56M -34.38M
Gross Margin 77.16% 78.06% 79.17% 80.93% 81.82% 82.64%
Operating Margin 24.00% 26.70% 32.99% 27.45% 28.66% 10.63%
Net Margin 18.27% 20.36% 22.14% 41.44% 11.33% -23.13%
Return on Equity (ROE) 18.24% 22.07% 27.59% 45.05% 18.55% -38.02%
Return on Assets (ROA) 12.48% 14.56% 15.88% 26.93% 7.98% -8.65%
Current Ratio 3.60× 3.31× 2.75× 5.07× 5.29× 1.95×
Debt-to-Equity 0.19× 0.28× 0.42× 0.48× 1.05× 2.00×
Effective Tax Rate 26.21% 24.14% 25.69% -73.35% 7.56% —
Cash Conversion Ratio 2.19× 1.51× 1.70× 0.80× 2.85× 0.08×
Accruals Ratio -0.15× -0.07× -0.11× 0.05× -0.15× -0.08×
SBC % of Revenue 5.17% 5.96% 5.45% 5.98% 5.13% 2.94%
CapEx Coverage 1123.22× 190.65× 703.16× 839.92× 330.73× -1492.50×
Free Cash Flow Per Share $5.94 $3.78 $3.63 $2.36 $1.66 $-0.12

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 13.81× 13.71× 15.16× 18.55× 73.52× —
P/FCF 6.30× 9.11× 8.90× 23.33× 25.69× —
FCF Yield 15.88% 10.98% 11.23% 4.29% 3.89% —
EV / EBITDA — 7.88× 7.94× 22.53× 23.22× 74.28×
P/S 2.49× 2.75× 3.15× 7.50× 8.21× 12.87×
P/B 2.48× 2.98× 3.93× 8.15× 13.45× 21.16×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenue from Contract with Customer, Excluding Assessed Tax 868.45M 714.73M 582.02M 437.86M 305.44M 159.74M
Cost of Goods and Services Sold 198.34M 156.81M 121.24M 83.48M 55.52M 27.74M
Gross Profit 670.11M 557.92M 460.79M 354.37M 249.92M 132.00M
Research and Development Expense 189.59M 145.82M 76.06M 70.89M 30.37M 19.45M
Operating Expenses 461.64M 367.09M 268.76M 234.19M 162.39M 115.02M
Operating Income (Loss) 208.47M 190.83M 192.03M 120.19M 87.53M 16.99M
Income Tax Expense (Benefit) 56.38M 46.31M 44.54M -76.78M 2.83M —
Net Income (Loss) Attributable to Parent 158.69M 145.49M 128.85M 181.47M 34.60M -36.94M
Earnings Per Share, Basic $2.76 $2.56 $2.17 $3.07 $0.60 $-2.48
Weighted Average Number of Shares Outstanding, Basic 57.49M 56.89M 59.47M 59.17M 57.53M 25.77M
Earnings Per Share, Diluted $2.71 $2.51 $2.13 $2.97 $0.58 $-2.48
Weighted Average Number of Shares Outstanding, Diluted 58.54M 57.87M 60.37M 61.10M 59.21M 25.77M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 752.50M 453.00M 311.66M 243.78M 234.31M 228.63M
Assets, Current 907.01M 579.25M 451.07M 400.29M 284.44M 262.89M
Assets 1.27B 999.20M 811.45M 673.87M 433.44M 427.07M
Long-term Debt 163.66M 179.27M 193.57M 191.65M 191.98M 194.25M
Liabilities, Current 252.13M 175.08M 163.78M 78.88M 53.77M 134.54M
Long-term Debt, Excluding Current Maturities 143.66M 163.02M 178.57M 189.65M 189.98M 194.25M
Liabilities 401.41M 340.05M 344.46M 271.03M 246.94M 329.89M
Stockholders' Equity Attributable to Parent 870.22M 659.15M 466.99M 402.84M 186.51M 97.18M
Common Stock, Shares, Outstanding 57.73M 57.14M 56.77M 59.62M 58.83M 56.89M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 348.20M 219.82M 219.39M 144.47M 98.56M -2.98M
Payments to Acquire Property, Plant, and Equipment 310.00K 1.15M 312.00K 172.00K 298.00K 2.00K
Net Cash Provided by (Used in) Investing Activities -39.65M -67.48M -46.44M -141.83M -100.30M -2.00M
Payments for Repurchase of Common Stock — — 100.00M — — 167.00K
Net Cash Provided by (Used in) Financing Activities -9.05M -11.00M -105.55M 6.84M 7.42M 209.16M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (HRMY CIK 0001802665), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

AFBI

Affinity Bancshares, Inc.

FNB

FNB CORP/PA/

PD

PAGERDUTY, INC.